ABACUS MEDICINE A/S: Financial statements 2024
CVR: 28111576
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ABACUS MEDICINE A/S (CVR 28111576) has filed annual accounts for 2024. In 2024, the company reported revenue of EUR 1,486,964,000 and a net result of EUR 17,621,000 compared with EUR 20,042,000 the year before. That is an increase of 22.9% compared with the year before. The profit margin was 1.2%. Equity in the 2024 report amounted to EUR 95,895,000. The solvency ratio was 26.8%.
- Revenue
- EUR 1,486,964,000
- Profit/Loss
- EUR 17,621,000
- Equity
- EUR 95,895,000
- Total Assets
- EUR 357,304,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 1.5B EUR | - | 17.6M EUR | 95.9M EUR | - |
| 2023 | 1.2B EUR | - | 20M EUR | 80.9M EUR | - |
| 2022 | 1B EUR | - | 5.8M EUR | 61M EUR | - |
| 2021 | 940.7M EUR | - | 415K EUR | 54.6M EUR | - |
| 2020 | 663.5M EUR | - | 433K EUR | 53M EUR | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.551.a" issued by Amgros I/S worth 22,900,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.351.b" issued by Amgros I/S worth 22,702,680,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1163.a" issued by Amgros I/S worth 1,644,000,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.709.a" issued by Amgros I/S worth 145,756,745 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1208.b" issued by Amgros I/S worth 7,330,000 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1303.b" issued by Amgros I/S worth 14,267,938 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1201.a" issued by Amgros I/S worth 45,354,771 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1305.a" issued by Amgros I/S worth 91,145,340 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1200.a" issued by Amgros I/S worth 101,036,383 DKK.
ABACUS MEDICINE A/S has won the tender "Amgros 2025 1.1306.b" issued by Amgros I/S worth 18,679,198 DKK.
About ABACUS MEDICINE A/S
ABACUS MEDICINE A/S is a Danish company of the type Aktieselskab based in København V, founded in 2004. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ABACUS MEDICINE ApS. The management consists of Flemming Wagner. The board consists of Jens Albert Harsaae (chair), Alette Margaretha Verbeek, Anders Kunze Bønding and Flemming Wagner. The company is owned by Wagner Family Holding ApS and CHR. AUGUSTINUS FABRIKKER AKTIESELSKAB. The company has 388 employees (2026). In 2025, the company reported revenue of EUR 1,817,637,000 and a net result of EUR 7,779,000 compared with EUR 17,621,000 the year before. Equity in the 2025 report amounted to EUR 98,523,000.